PATENT CLAIM ANALYSIS

Application Number: 16275739
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "452000"]

Abstract:
The present invention provides novel pharmaceutical compositions of dimethyl fumarate. The pharmaceutical compositions of the present invention are in the form of a tablet and comprise one or more extended release polymer matrix. Also provided are pharmaceutical compositions in the form of a capsule comprising one or more tablets of the present invention. Methods of using the pharmaceutical compositions of the present invention for treating multiple sclerosis are also included.

Claim (Index 1):
A pharmaceutical composition in the form of a tablet comprising: (i) dimethyl fumarate as an active substance, wherein the active substance is present in the amount of 30-90% by weight of the tablet, and (ii) one or more extended release polymer matrix present in the amount of 1-70% by weight of the tablet, wherein the active substance is distributed throughout the matrix and wherein the tablet has an average of the length and the width in the range of 3.5-6.5 mm.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.89744
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13920538', '11766239', '11928908', '15536334', '10933479']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7209925080588119
- 35 USC 102 Novelty (BERT): 0.5177554877047164
- Combined Prediction Score: 0.7006688060234023
- Mean Citation Score: 263.162302
- Max Citation Score: 283.215
- Similarity Product: 164.97443707197905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test